Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) Shares Outstanding (Weighted Average) (2016 - 2025)

HealthLynked (HLYK) has disclosed Shares Outstanding (Weighted Average) for 10 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 11020.21% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2025, up 11020.21% year-over-year, with the annual reading at $2.8 million for FY2025, 11020.21% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $2.8 million at HealthLynked, roughly flat from $2.8 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $265.5 million in Q3 2023, with the low at $25000.0 in Q3 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $114.4 million, with a median of $40.0 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) crashed 99.99% in 2024, then soared 11195.22% in 2025.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $3.1 million in 2021, then skyrocketed by 7841.2% to $243.4 million in 2022, then grew by 8.0% to $262.9 million in 2023, then crashed by 99.99% to $25501.0 in 2024, then skyrocketed by 11020.21% to $2.8 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $2.8 million, $2.8 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.